D. Călugăru

D. Călugăru, M. Călugăru, 2015, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study.

D. Călugăru, M. Călugăru, 2016, American journal of ophthalmology.

[Neovascular glaucoma--etipathogeny and diagnosis].

D. Călugăru, M. Călugăru, 2012, Oftalmologia.

Ocular hypertension in patients with central/hemicentral retinal vein occlusions: cumulative prevalence and management.

D. Călugăru, M. Călugăru, Ș. Ţălu, 2018, International journal of ophthalmology.

Dexamethasone intravitreal implant in retinal vein occlusion:real-life data from a prospective, multicenter clinical trial

D. Călugăru, M. Călugăru, 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study

D. Călugăru, M. Călugăru, 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France

D. Călugăru, M. Călugăru, 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.

Romanian ophthalmologists in the renowned ophthalmic journals worldwide

D. Călugăru, M. Călugăru, 2018, Romanian journal of ophthalmology.

Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the Ranidex study

D. Călugăru, M. Călugăru, 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

Pro-permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; The Ozurdex for Retinal Vein Occlusion (ORVO) Study.

D. Călugăru, M. Călugăru, 2016, American journal of ophthalmology.

Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.

D. Călugăru, M. Călugăru, 2015, American journal of ophthalmology.

Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.

D. Călugăru, M. Călugăru, 2018, American journal of ophthalmology.

Safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience

D. Călugăru, M. Călugăru, 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

Re: Yeh et al.: Ophthalmic Technology Assessment: therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology (Ophthalmology 2015;122:769-78).

D. Călugăru, M. Călugăru, 2015, Ophthalmology.

Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data

D. Călugăru, M. Călugăru, 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

Bevacizumab in the treatment of acute central/hemicentral retinal vein occlusions.

D. Călugăru, M. Călugăru, Ș. Ţălu, 2016, Romanian journal of ophthalmology.

Comment on: ‘Central retinal vein occlusion: modifying current treatment protocols’

D. Călugăru, M. Călugăru, 2016, Eye.

Effect of aflibercept on refractory macular edema associated with central retinal vein occlusion.

D. Călugăru, M. Călugăru, 2017, Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie.

Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex) in its treatment

D. Călugăru, M. Călugăru, 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.

Comment on ‘The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary’

D. Călugăru, M. Călugăru, 2015, Eye.

Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA

D. Călugăru, M. Călugăru, 2015, Eye.

Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema

D. Călugăru, M. Călugăru, 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Central Retinal Vein Occlusion.

D. Călugăru, M. Călugăru, 2017, American journal of ophthalmology-glaucoma.

Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion

D. Călugăru, M. Călugăru, 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

Switching from ranibizumab and aflibercept to bevacizumab therapy in neovascular age-related macular degeneration patients

D. Călugăru, M. Călugăru, 2020, European journal of ophthalmology.

Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice.

D. Călugăru, M. Călugăru, 2018, American journal of ophthalmology.

Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome.

D. Călugăru, M. Călugăru, 2017, American journal of ophthalmology.

Comments to: Restoration of photoreceptors in eyes with diabetic macular edema

D. Călugăru, M. Călugăru, 2018, European journal of ophthalmology.

Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success

D. Călugăru, M. Călugăru, 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment

D. Călugăru, M. Călugăru, 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

Comments to: Ranibizumab for Persistent Diabetic Macular Edema after Bevacizumab Treatment

D. Călugăru, M. Călugăru, 2017, European journal of ophthalmology.

Comments to: Long-Term Efficacy and Safety of Intravitreal Dexamethasone Implant for the Treatment of Diabetic Macular Edema

D. Călugăru, M. Călugăru, 2016, European journal of ophthalmology.

Ischemic retinal vein occlusion: Characterizing the more severe spectrum of retinal vein occlusion.

D. Călugăru, M. Călugăru, 2019, Survey of ophthalmology.

Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion.

D. Călugăru, M. Călugăru, 2017, American journal of ophthalmology.

Re: Khurana et al.: Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study (Ophthalmol Retina. 2017).

D. Călugăru, M. Călugăru, 2017, Ophthalmology. Retina.

Comment on: ‘Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab’

D. Călugăru, M. Călugăru, 2016, Eye.

[Fixed combinations of glaucoma medications].

D. Călugăru, M. Călugăru, 2008, Oftalmologia.

Characterisation of human non-proliferative diabetic retinopathy using the fractal analysis.

Ştefan Ţălu, C. Lupascu, D. Călugăru, 2015, International journal of ophthalmology.

What We Have Learned From the Ocular Hypertension Treatment Study.

D. Călugăru, M. Călugăru, 2018, American journal of ophthalmology.

Early treatment with dexamethasone intravitreal implants in diabetic macular edema: Naïve versus refractory patients

D. Călugăru, M. Călugăru, 2022, European journal of ophthalmology.

Etiology, pathogenesis, and diagnosis of neovascular glaucoma.

D. Călugăru, M. Călugăru, 2022, International journal of ophthalmology.

Correspondence

D. Călugăru, M. Călugăru, 1962, Pain.

Comment on "Anatomical and functional changes after dexamethasone implant and ranibizumab in diabetic macular edema: a retrospective cohort study".

D. Călugăru, M. Călugăru, 2020, International journal of ophthalmology.

Central retinal vein occlusion in a young adult Case report.

D. Călugăru, M. Călugăru, 2016, Romanian journal of ophthalmology.

Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up (BERVOLT study: bevacizumab for RVO long-term follow-up)

D. Călugăru, M. Călugăru, 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.

Comment on: ‘Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’

D. Călugăru, M. Călugăru, 2016, Eye.

Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.

D. Călugăru, M. Călugăru, 2015, American journal of ophthalmology.